Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Eclipse: Flotufolastat F 18 to Determine Treatment Success Following Prostate Focal Therapy

NCT07185165 is registered in ClinicalTrials.gov with Jonsson Comprehensive Cancer Center as lead sponsor.

NCT NCT07185165
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07185165 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Eclipse: Flotufolastat F 18 to Determine Treatment Success Following Prostate Focal Therapy
Lead sponsor
Jonsson Comprehensive Cancer Center
Phase
Phase 2
Overall status
Recruiting
Start date
October 9, 2025
Completion date
October 25, 2036
Enrollment
81 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate carcinoma